Gulf International Bank UK Ltd Sells 99 Shares of Humana Inc. (NYSE:HUM)

Gulf International Bank UK Ltd decreased its stake in shares of Humana Inc. (NYSE:HUM) by 1.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,767 shares of the insurance provider’s stock after selling 99 shares during the quarter. Gulf International Bank UK Ltd’s holdings in Humana were worth $2,477,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HUM. Creative Financial Designs Inc. ADV lifted its holdings in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after buying an additional 61 shares in the last quarter. FPC Investment Advisory Inc. bought a new stake in Humana during the 4th quarter valued at about $27,000. Centricity Wealth Management LLC purchased a new position in Humana during the 4th quarter valued at about $30,000. Ashton Thomas Securities LLC purchased a new position in Humana during the 3rd quarter valued at about $31,000. Finally, Atwood & Palmer Inc. increased its position in Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 60 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Shares of NYSE HUM opened at $270.91 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a 50 day simple moving average of $271.11 and a two-hundred day simple moving average of $287.34. The stock has a market cap of $32.68 billion, a price-to-earnings ratio of 27.23, a PEG ratio of 2.05 and a beta of 0.56.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.31%. The ex-dividend date is Friday, March 28th. Humana’s payout ratio is 35.58%.

Insider Buying and Selling at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.32% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on HUM. Piper Sandler raised their target price on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Morgan Stanley cut their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. StockNews.com raised shares of Humana from a “hold” rating to a “buy” rating in a research report on Tuesday. Cantor Fitzgerald reissued a “neutral” rating and set a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. Finally, Truist Financial raised their target price on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Nineteen analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $285.68.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.